Hittmair A - Search Results

1

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.

Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H. Culig Z, et al. Among authors: hittmair a. Br J Cancer. 1999 Sep;81(2):242-51. doi: 10.1038/sj.bjc.6690684. Br J Cancer. 1999. PMID: 10496349 Free PMC article.

2

Activation of the androgen receptor by polypeptide growth factors and cellular regulators.

Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H. Culig Z, et al. Among authors: hittmair a. World J Urol. 1995;13(5):285-9. doi: 10.1007/BF00185971. World J Urol. 1995. PMID: 8580999 Review.

3

Androgen receptor status of lymph node metastases from prostate cancer.

Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A. Hobisch A, et al. Among authors: hittmair a. Prostate. 1996 Feb;28(2):129-35. doi: 10.1002/(SICI)1097-0045(199602)28:2<129::AID-PROS9>3.0.CO;2-B. Prostate. 1996. PMID: 8604394

4

Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.

Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H. Culig Z, et al. Among authors: hittmair a. Cancer Detect Prev. 1996;20(1):68-75. Cancer Detect Prev. 1996. PMID: 8907206

5

Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapy.

Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Bartsch G, Klocker H. Culig Z, et al. Among authors: hittmair a. Drugs Aging. 1997 Jan;10(1):50-8. doi: 10.2165/00002512-199710010-00005. Drugs Aging. 1997. PMID: 9111707 Review.

6

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells.

Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Zhang J, Bartsch G, Klocker H. Culig Z, et al. Among authors: hittmair a. Prostate. 1997 Jul 1;32(2):106-14. doi: 10.1002/(sici)1097-0045(19970701)32:2<106::aid-pros5>3.0.co;2-k. Prostate. 1997. PMID: 9215398

7

Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?

Culig Z, Hobisch A, Hittmair A, Peterziel H, Radmayr C, Bartsch G, Cato AC, Klocker H. Culig Z, et al. Among authors: hittmair a. Histol Histopathol. 1997 Jul;12(3):781-6. Histol Histopathol. 1997. PMID: 9225161 Review.

8

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.

Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato AC, Bartsch G, Klocker H. Culig Z, et al. Among authors: hittmair a. Prostate. 1998 Apr 1;35(1):63-70. doi: 10.1002/(sici)1097-0045(19980401)35:1<63::aid-pros9>3.0.co;2-i. Prostate. 1998. PMID: 9537601 Review.

9

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H, Konwalinka G. Culig Z, et al. Among authors: hittmair a. Br J Cancer. 1998 Oct;78(8):1004-11. doi: 10.1038/bjc.1998.619. Br J Cancer. 1998. PMID: 9792142 Free PMC article.

10

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. Culig Z, et al. Among authors: hittmair a. Cancer Res. 1994 Oct 15;54(20):5474-8. Cancer Res. 1994. PMID: 7522959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters